The protocol for the Cannabidiol in children with refractory epileptic encephalopathy (CARE-E) study: a phase 1 dosage escalation study.

Darren ReithmeierRichard Tang-WaiBlair SeifertAndrew W LyonJane AlcornBryan ActonScott CorleyErin Prosser-LooseDarrell D MousseauHyun J LimJose Tellez-ZentenoLinda HuhEdward LeungLionel CarmantRichard James Huntsman

Published in: BMC pediatrics (2018)

http://clinicaltrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2016 Dec 16. Identifier NCT03024827, Cannabidiol in Children with Refractory Epileptic Encephalopathy: CARE-E; 2017 Jan 19 [cited 2017 Oct]; Available from: http://clinicaltrials.gov/ct2/show/NCT03024827.

Keyphrases

healthcare
quality improvement
young adults
palliative care
randomized controlled trial
early onset
computed tomography
magnetic resonance imaging
pain management
clinical trial
diabetic retinopathy
open label
image quality
health insurance
contrast enhanced
dual energy
fine needle aspiration